Common use of Department Responsibilities Clause in Contracts

Department Responsibilities. 4.1 The Department shall publish a PDL/RDL inclusive of Preferred/Recommended Products that: (a) Shall not be discouraged or disadvantaged in any way relative to any other drug product in its therapeutic class unless specifically stated otherwise in the Contracted Products Attachment of this Agreement. (b) Shall not be subject to clinical edits, prior authorization, step therapy or similar utilization management controls that are more stringent than the FDA-approved product labeling unless specifically stated otherwise in the Contracted Products Attachment of this Agreement. 4.2 The established PDL and RDL shall be state run and utilized for the Medicaid Population. 4.3 The Department will provide Medicaid PDL/RDL Utilization to the Manufacturer within ninety (90) days of the last day of each Quarter. Medicaid PDL/RDL Utilization data to be supplied includes, for each NDC number: 1) Product name;